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Abstract: Brain plasticity is the basis for systems-level functional reorganization that promotes recovery
in multiple sclerosis (MS). As inflammation interferes with plasticity, its pharmacological modulation
may restore plasticity by promoting desired patterns of functional reorganization. Here, we tested the
hypothesis that brain plasticity probed by a visuomotor adaptation task is impaired with MS inflam-
mation and that pharmacological reduction of inflammation facilitates its restoration. MS patients were
assessed twice before (sessions 1 and 2) and once after (session 3) the beginning of Interferon beta
(IFN beta), using behavioural and structural MRI measures. During each session, 2 functional MRI
runs of a visuomotor task, separated by 25-minutes of task practice, were performed. Within-session
between-run change in task-related functional signal was our imaging marker of plasticity. During ses-
sion 1, patients were compared with healthy controls. Comparison of patients’ sessions 2 and 3 tested
the effect of reduced inflammation on our imaging marker of plasticity. The proportion of patients
with gadolinium-enhancing lesions reduced significantly during IFN beta. In session 1, patients dem-
onstrated a greater between-run difference in functional MRI activity of secondary visual areas and
cerebellum than controls. This abnormally large practice-induced signal change in visual areas, and in
functionally connected posterior parietal and motor cortices, was reduced in patients in session 3 com-
pared with 2. Our results suggest that MS inflammation alters short-term plasticity underlying motor
practice. Reduction of inflammation with IFN beta is associated with a restoration of this plasticity,
Contract grant sponsor: Merck Serono Switzerland, the Du Pre
Grant from the Multiple Sclerosis International Federation
(http://www.multiple sclerosisif.org) 2011 (V.T.) and 2014
(A.d.A.), and the Italian Ministry of Health (V.T.) (Ministero della
Salute, Progetto Giovani Ricercatori 100/GR-2009-1580131)
*Correspondence to: Dr. Valentina Tomassini, MD, PhD, Institute
of Psychological Medicine and Clinical Neurosciences, Cardiff
University School of Medicine, University Hospital of Wales,
Heath Park, CF14 4XN Cardiff, United Kingdom. E-mail: tomassi-
niv@cardiff.ac.uk
The first two authors contributed equally to this work.
Received for publication 25 September 2015; Revised 4 March
2016; Accepted 7 March 2016.
DOI: 10.1002/hbm.23184
Published online 18 March 2016 in Wiley Online Library
(wileyonlinelibrary.com).
r Human Brain Mapping 37:2431–2445 (2016) r
VC 2016 The Authors Human Brain Mapping Published by Wiley Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited.
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INTRODUCTION
The neural reorganization that mitigates the functional
impact of damage [Enzinger and Fazekas, 2015] and pro-
motes recovery in multiple sclerosis (MS) is based on brain
plasticity [Tomassini et al., 2012a] that is the dynamic reor-
ganization of brain function in response to experience
(e.g., skill learning) [Doyon and Benali, 2005; Nudo 2013]
or damage [Nudo, 2013]. Advanced neuroimaging shows
that clinically meaningful functional changes occur during
and after an active phase of MS [Lee et al., 2000; Mezza-
pesa et al., 2008; Pantano et al., 2002, 2005]. With this func-
tional compensation, damage-related altered patterns of
functional reorganisation occur in MS, even early during
the course of the disease [Pantano et al., 2002] or in the
presence of preserved [Hulst et al., 2012] or fully recov-
ered behaviour [Reddy et al., 2000]. These patterns of
functional reorganisation differ from those of healthy vol-
unteers even when recovery interventions drive perform-
ance improvements in the patients [Tomassini et al.,
2012b]. While disability per se can sustain these abnormal
patterns [Reddy et al., 2002], evidence suggests that MS
inflammatory damage independently contributes to them
[Lee et al., 2000; Reddy et al., 2002]. The effects of inflam-
mation and its modulation on brain plasticity, however,
remain largely unexplored, hampering the development of
effective strategies enhancing recovery of function in MS
patients [Tomassini et al., 2012a].
Indeed, experimental findings suggest that immune
mediators, chronically over-expressed in the MS inflamma-
tory process, can affect the brain mechanisms underlying
functional recovery by interfering with biochemical interac-
tions, from a neuronal to a neurovascular level. Firstly,
inflammation can influence the synaptic transmission,
impairing the ability to encode and retain information [Di
Filippo et al., 2014; Hauss-Wegrzyniak et al., 2002; Min
et al., 2009]. Electrophysiological studies support this mech-
anism [Mori et al., 2014; Nistico et al., 2013] and link it to
clinically significant deficits [Mori et al., 2011]. Secondly,
inflammation can damage connections between brain
regions, hindering the spatial and temporal coherence of
signal transmission [Allan and Rothwell, 2001; Di Filippo
et al., 2008] necessary for plasticity to effectively drive
recovery [Robertson and Murre, 1999]. Indeed, systems-
level plasticity relies on long-range connections between
brain regions. Damage to these connections occurs in MS
[He et al., 2009; Petsas et al., 2013] and induces aberrant
neural connectivity among widely distributed brain regions
[Rocca et al., 2009]. Thirdly, inflammation can alter the neu-
rovascular coupling [Girouard and Iadecola, 2006], a funda-
mental function of the brain that is the balance between
energy demand imposed by neural activity and substrate
delivery through blood flow, by interfering with the bio-
chemical milieu that regulates the vasoactive chemicals sup-
porting the normal neurovascular interactions.
As inflammation can interfere with brain plasticity in
MS, its pharmacological modulation may restore plasticity
by promoting desired patterns of brain functional reorgan-
ization. In this proof of concept study, we use advanced
imaging methods to test whether brain plasticity is
impaired as a result of MS inflammation and if a pharma-
cological reduction of inflammation through Interferon
(IFN) beta may restore this plasticity. IFN beta reduces
inflammatory activity in MS through a modulation of the
pro-inflammatory environment in the central nervous sys-
tem (CNS) [Whitaker, 1994] that contributes to altered
plasticity [Di Filippo et al.. 2014]. In patients with MS, the
effects of IFN beta on MRI disease activity can be detected
4 weeks after the beginning of high dose IFN beta [De Ste-
fano et al., 2012], suggesting that an early anti-
inflammatory effect can be expected in patients.
To probe plasticity and its changes over time, we used
practice of a simple motor task that induces short-term
motor adaptation [Morgen et al., 2004], i.e., changes in
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sensorimotor cortical excitability and/or in the location or
extent of cortical representations following repeated task
execution that represent an optimized recruitment of the
sensory-motor network with practice [Butefisch et al.,
2000; Classen et al., 1998; Hagenbeek et al., 2007]. The
repetitive performance of simple and unskilled, but over-
learned movements can cause representational changes in
MS patients that can be measured using functional MRI
(fMRI) [Mancini et al., 2009]. Here, we hypothesised that
training of these simple movements, requiring no fine
hand coordination and very little strength, and inducing
short-term motor adaptation, caused brain functional
changes that (i) were detectable in the MS patients, (ii)
were altered as a result of inflammation and (iii) could be
restored with immunomodulation.
MATERIALS AND METHODS
Participants and Study Design
Right-handed patients with a diagnosis of MS according
to the revised McDonald Criteria [Polman et al., 2005] and
eligible to start treatment with IFN beta were recruited at
Sapienza University of Rome. Steroid administration and
relapse within 3 months of study entry were exclusion crite-
ria. Patients were assessed using behavioural and MRI
measures twice before (at session 1, week266 1, and at ses-
sion 2, baseline) and once after (at session 3, week 1126 1)
the beginning of IFN beta 1a 44 mcg (RebifVR , Merck Serono)
subcutaneously administered 3 times weekly. The interval
between sessions was chosen in order to balance the need to
avoid a delay in treatment initiation for eligible patients,
considered unethical, with the necessity to allow for a suffi-
cient period of time for the drug to manifest an effect on
MRI activity [De Stefano et al., 2012; Pozzilli et al., 1996].
Age- and sex-matched healthy volunteers were assessed
behaviourally and with MRI at session 1 only. Figure 1
reports the details of the study design and measurements.
Participants’ written informed consent was obtained
according to the Declaration of Helsinki and the protocol
approved by the local Ethics Committee.
Behavioural Measures and Statistical Analysis
During each session, participants were assessed using
the Nine Hole Peg Test (9-HPT), the Timed 25-Foot Walk
Figure 1.
Study design and measurements. Patients were assessed using
behavioural and MRI measures twice before (at session 1, week
266 1, and at session 2, baseline) and once after (at session 3,
week 1126 1) the beginning of IFN beta. Age- and sex-matched
healthy volunteers were assessed behaviourally and with MRI at
session 1 only. During each session, participants were assessed
using behavioural measures. Patients were also assessed using the
EDSS score. Patients underwent conventional MRI acquisitions to
detect the presence and quantify the number of Gd-enhancing and
T2-hyperintense lesions, and to quantify GM volume. Motor task
fMRI consisting of the repetition of directionally specific, volun-
tary, visually cued TF movements before (run 1) and after (run 2)
25 minutes of TF training was acquired in MS patients in the three
scanning sessions and in healthy volunteers in session 1. The fMRI
data analysis tested (a) within- and between-group changes in
brain activation associated with training at session 1; (b) changes
in training-related functional responses with IFN beta in the
patients. Abbreviations: EDSS5 Expanded Disability Status Scale;
fMRI5 functional MRI; Gd5 Gadolinium; IFN5 Interferon; GM5
Grey Matter; 9-HPT5 Nine Hole Peg Test; PASAT5 Paced Audi-
tory Serial Addition Test; S5 Session; T25-FW5 Timed 25-Foot
Walk; TF5 Thumb Flexion; WI5Weighted Image.
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(T25-FW) and the Paced Auditory Serial Addition Test
(PASAT) 2s and 3s that are part of the MS Functional
Composite (Cutter, Brain 1999). Patients were also assessed
using the Expanded Disability Status Scale (EDSS) score
[Kurtzke, 1983].
We used two-tailed unpaired t-test to investigate
between-group differences in age and behavioural meas-
ures. We used chi-square test to assess sex differences
between groups. To investigate changes in behavioural
measures across sessions in patients we used repeated
measures ANOVA followed by two-tailed paired t-tests
that identified changes between pairs of sessions. For all
the statistical tests, differences were considered significant
at P 0.05. Values are reported as mean6 standard error
(SE), unless stated otherwise.
MRI Acquisitions and Analysis
Structural and functional MRI measurements were
acquired using a Siemens Magnetom Verio 3T/70cm bore
magnet (Siemens healthcare, Siemens, Germany). Analysis
was carried out using tools from the FMRIB Software
Library (FSL) (www.fmrib.ox.ac.uk/fsl) [Smith et al., 2004]
and software for lesion volume quantification (Jim 5.0 soft-
ware, Xinapse System, Leicester, UK; http://www.xinapse.
com). All brain functional activations were labelled using
the Montreal Neurological Institute (MNI) Structural Atlas,
Harvard-Oxford Structural Atlas, the Juelich Histological
Atlas, the Cerebellar Atlas in MNI and the Oxford Thalamic
Connectivity Probability Atlas (http://www.fmrib.ox.ac.
uk/fsl/data/atlas-descriptions.html).
Structural MRI
Patients underwent conventional MRI acquisitions that
included T1-weighted images (WIs) [Repetition Time
(TR)5 550 ms; Echo Time (TE)5 9.8 ms; Field of View
(FOV) 5240 mm; matrix5 320 3 320; 25 axial slices, 4 mm
thickness; 30% gap], acquired 5 minutes after the adminis-
tration of Gadolinium (Gd) to detect the presence and
quantify the number of Gd-enhancing lesions; proton den-
sity and T2-WIs (TR5 3,320 ms; TE15 10 ms; TE25 103
ms; FOV5 220 mm; matrix5 384 3 384; 25 axial slices;
4 mm thickness; 30% gap) to quantify T2-hyperintense
lesions; high resolution 3D T1-WIs (2 acquisitions of 1 mm
voxel size MPRAGE sequence with TR5 1,900 ms; TE5
2.93 ms; flip angle5 98; FOV5 260 mm; matrix5 256 3
256; 176 sagittal slices; 1 mm thickness; no gap) to quantify
grey matter (GM) volume. Healthy volunteers underwent
3D T1-WIs only at session 1.
A trained researcher (F.T.) assessed the presence of Gd-
enhancing lesions on the post-contrast T1-WIs and calcu-
lated the volume of T2-hyperintense lesions on T2-WIs
using a semiautomated technique (Jim 5.0 software,
Xinapse System, Leicester, UK; http://www.xinapse.com).
The statistical significance of the difference in the propor-
tion of Gd-positive vs. Gd-negative scans was calculated
using a non-parametric binomial test with a significance
level of P 0.05. 3D T1-WIs were analyzed with FSL-
Voxel-Based Morphometry (VBM) [Ashburner and Friston,
2000; Good et al., 2001], incorporating non-linear registra-
tion and correction for local expansion or contraction to
produce the GM template that was used as a covariate in
the fMRI analysis to control for local differences in GM
volume between patients and controls at session 1.
Functional MRI
Motor task fMRI was acquired in MS patients in the
three scanning sessions and in healthy volunteers in ses-
sion 1. Whole brain functional images with blood oxygen
level dependent (BOLD) contrast were obtained using
gradient-echo echo-planar imaging (TR/TE5 3,000/30ms,
64x64 matrix, 50 transverse interleaved 3 mm slices, FOV
192 mm, flip angle 898). Fieldmaps were also generated
(TR5 488ms, TE15 4.92ms, TE25 7.38ms, 3 mm voxel
size, 36 3-mm interleaved transverse slices, FOV 250 mm,
64 3 64 matrix, flip angle 608) for each individual to aid
registration.
The motor task consisted of the repetition of direction-
ally specific, voluntary, visually cued thumb flexion (TF)
movements before (run 1) and after (run 2) 25 minutes of
TF training [Morgen et al., 2004]. Participants performed
30-second blocks of TF alternated with 30-second blocks of
rest. A colour fixation cross, flashing between orange (TF)
and white (thumb relaxing with return to resting position)
every 0.5 seconds, was used as cue to obtain a rate of 1 Hz
TF. A 3-second instruction of either “Flexion” or “Rest”
condition preceded each block. The flashing cross was
present throughout both conditions. Task instructions and
pacing were visually presented using a MRI-compatible
stimulus-presentation system with the use of goggles
(VisuaStim Digital system from Resonance Technology Inc,
Northridge, California). A researcher monitored the execu-
tion of the task to ensure consistency throughout the
experiment.
The fMRI data analysis tested (a) within- and between-
group changes in brain activation associated with training
at session 1; (b) changes in training-related functional
responses with IFN beta in the patients. Analysis was car-
ried out using FEAT of FSL. The direction of functional
contrasts is indicated in the text as vs., e.g. run 1 vs. run 2
indicates run 1 - run 2 and run 2 vs. run 1 indicates run 2
- run 1.
First-level analysis (step1) was conducted in each partici-
pant and in each run to identify the main effect of the TF
task. Data pre-processing included motion correction,
brain extraction, spatial smoothing (Gaussian kernel of 5-
mm full width at half maximum), high-pass temporal filter
(100-s cut off) and correction for field inhomogeneities
through fieldmap-based echo-planar imaging unwarping.
Non-linear registration from high-resolution T1 structural
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to MNI standard brain space was carried out. The time
series was analyzed using a general linear model approach
with local autocorrelation correction. The canonical gamma
variate hemodynamic response function was used. One
explanatory variable (along with the temporal derivative)
specified the onset and duration of the task periods to
identify the mean effect associated with the task for both
run 1 and run 2. Mixed effects, within session, higher-level
(group) analyses were conducted in patients and in con-
trols [Beckmann et al., 2003] to identify the main effect of
the task for run 1 and for run 2. Group Z statistical images
were thresholded using clusters determined by Z> 2.3 and
a cluster-extent corrected significance threshold of P 5
0.05 [Forman et al., 1995; Friston et al., 1994; Worsley
et al., 1992].
Fixed effects, within-session, higher-level (group) analy-
ses (step 2) were conducted in patients and in controls
[Beckmann et al., 2003] to identify within-subject between-
run signal changes in functional responses. Within-session
between-run percent signal changes in functional
responses represented the practice-related change in brain
activity that was our imaging marker of training-related
brain plasticity [Morgen et al., 2004].
Mixed effects, within-session, higher-level (group) analy-
ses (step 3) to investigate the mean between run signal
changes in both groups and to compare groups were con-
ducted for session 1 [Beckmann et al., 2003] with auto-
matic outlier de-weighting [Woolrich, 2008]. GM partial
volume information based on the individual structural
images was added to the model as a voxel-dependent
covariate. Group Z statistical images were thresholded
using clusters determined by Z> 2.3 and a cluster-extent
corrected significance threshold of P5 0.05.
Mixed effects, between-session, within-group paired
higher-level (group) analysis (step 4) was carried out with
automatic outlier de-weighting to detect changes in
between-run fMRI signal differences between sessions 2
and 3 in the patients. Group Z statistical images were
thresholded using clusters determined by Z> 2.3 and a
cluster-extent corrected significance threshold of P5 0.05.
Between-run (session 2 vs. session 3) percent signal change
in functional responses for the trained movements was
considered as representing brain plasticity modulated by
IFN beta anti-inflammatory effects, an assumption dis-
cussed further below.
Considering the longitudinal design of the study and
the absence of a placebo patient group, it not being ethi-
cally acceptable to withhold IFN beta treatment from a
group of eligible patients, we expected that between-ses-
sion differences in between-run changes in functional
activity could be related to both a drug effect and a time
effect not caused by the drug, but reflecting the natural
history of reduction in MRI detectable active inflammation
[Ciccarelli et al., 1999]. Therefore, for the purposes of
exploring these effects in our data, without statistical test-
ing, in the Discussion, we plotted the results of the
between-run changes in functional response using the
fMRI signal extracted from the functionally defined, ana-
tomically constrained, regions of interest (ROIs) within the
cortical areas of the session 2 vs. session 3 group analysis
(from step 4). Anatomical constraints were applied by mul-
tiplying the masks of the significant cortical areas (motor,
parietal, temporal and visual cortices) from the MNI Struc-
tural Atlas with the binarized functional maps, thresh-
olded using clusters determined by Z> 2.3.
RESULTS
Demographic and Clinical Characteristics
A total of 26 MS patients and 22 healthy volunteers
were recruited. The demographic and clinical characteris-
tics of the patients and healthy volunteers are reported in
Table I. Of the 26 patients who entered the study and
completed the first assessment, 24 underwent all the scan-
ning sessions. Two patients dropped out: one, after session
1, due to pregnancy and the other, after session 2, due
protocol violation. In the 24 patients who completed the
study, the mean6 SE overall study duration was
128.76 4.8 days, with 45.26 2.0 days between sessions 1
and 2 and 84.56 4.2 days between sessions 2 and 3. Dur-
ing the study, there was no significant change in the EDSS
scores or in the mean T25-FW. A significant improvement
in the mean 9-HPT was observed for the dominant hand
(F5 9.0, df5 1.9, P5 0.001) between sessions 1 and 2
(17.76 0.4 vs. 16.86 0.4, P5 0.02), and for the non-
dominant hand (F5 3.6, df5 1.5, P5 0.05) between ses-
sions 2 and 3 (18.56 0.5 vs. 17.86 0.5, P5 0.03). The
PASAT 3s (F5 15.2, df5 1.9, P< 0.0001) showed a signifi-
cant change between sessions 1 and 2 (43.16 1.9 vs.
49.26 1.9, P< 0.0001), while the PASAT 2s (F5 10.4,
df5 1.8, P< 0.0001) significantly changed both between
sessions 1 and 2 (32.46 2.6 vs. 35.86 2.3, P< 0.0001) and
between sessions 2 and 3 (35.86 2.3 vs. 38.96 2.8,
P< 0.0001). None of the patients received steroids or expe-
rienced onset of new symptoms or worsening of previ-
ously reported symptoms during the study period.
Structural MRI Results
The initial structural MRI characteristics of the 26
patients who entered the study are reported in Table I.
Fourteen out of 26 (54%) MS patients during session 1 and
11 out 25 (44%) during session 2 had MRI scans with at
least one Gd-enhancing lesion, with no significant differ-
ence in the number of Gd-positive vs. Gd-negative scans
(P5 0.5). At session 3 (on IFN beta), the number of Gd-
active scans (3 out of 24) reduced by 72% compared to ses-
sion 2, with a significant difference in the number of Gd-
positive vs. Gd-negative scans (P5 0.001).
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Functional MRI Results
The fMRI analysis was performed on 26 patients at ses-
sion 1 and on 24 patients for sessions 2 and 3 of the study.
All participants performed the functional task and training
appropriately and completed the experimental protocol. In
session 1, during run 1 (step 1 of fMRI analysis), the TF
task engaged a large bilateral cluster of regions including
the primary motor, premotor, posterior parietal and occipi-
tal cortices, as well as the basal ganglia and the cerebellum
in both groups (Table II). This cluster of regions was more
extended in patients than in controls, including the left
primary somatosensory cortex and the right V3 area in
patients (Table II).
The within-group between-run (run 1 vs. run 2) changes
in fMRI responses during session 1 (step 3 of fMRI analy-
sis) are reported in Fig. 2 and in Table III for both patients
and healthy controls. These changes involved a cluster of
regions that included the prefrontal, premotor, primary
sensorimotor, posterior somatosensory and visual cortices,
as well as the basal ganglia and the cerebellum. During
session 1, patients showed a greater between-run (run 1
vs. run 2) signal reduction than controls in fMRI activity of
secondary visual areas (V2 and V4) and cerebellum (lobule
V-VI) (Fig. 2 and Table III).
There was an increase in fMRI responses during session
1 (run 2 vs. run 1) that involved the right angular gyrus
and posterior cingulate gyrus bilaterally in the patients,
and the right inferior parietal lobule and cingulate gyrus
bilaterally in the healthy volunteers, with no significant
between-group difference (data not shown).
Between-run changes in fMRI activity in the patients for
sessions 2 and 3 (step 4 of fMRI analysis) are reported in
Fig. 3 and in Table III. There was a reduction in the activa-
tion of cortical areas (run 1 vs. run 2) across sessions.
Between sessions 2 (before IFN beta) and 3 (on IFN beta),
patients showed a reduction of the between-run signal
change in the secondary visual areas (V2), as well, as in
motor, temporal and parietal cortical areas (Fig. 3 and
Table III). There was no increase in the activation of corti-
cal regions (run 1 vs. run 2) across sessions (session 3 vs.
session 2).
DISCUSSION
Our results suggest that MS inflammation alters plastic-
ity underlying short-term training of a simple motor task
[Morgen et al., 2004], as reflected in abnormally greater
practice-related fMRI signal changes in the patients com-
pared to healthy volunteers that were over and above
structural differences in GM volume. Indeed, in session 1,
patients showed a greater between-run reduction than
controls in fMRI activity of secondary visual areas and cer-
ebellum (Fig. 2). This larger practice-induced signal change
in visual areas and in functional connected regions [Rizzo-
latti and Luppino, 2001] was reduced in the patients in
session 3 compared with session 2 (Fig. 3), i.e., while on
IFN beta, suggesting that a reduction of inflammation with
IFN beta is accompanied by a restoration of systems-level
brain plasticity in the patients.
MS inflammatory Activity on MRI and Its
Changes With IFN Beta Treatment
Not all the MS patients who entered the study showed
Gd-enhancing lesions in their brains at the time of the
baseline MRI scan. However, neuropathological evidence
demonstrates that inflammatory activity typically spreads
well beyond lesions visible on conventional MRI [Moll
et al., 2011]. Indeed, conventional MRI is able to capture
only part of the pathological processes underlying MS
damage [Barkhof, 2002]. Also, Gd-enhancing lesions repre-
sent a snapshot of inflammatory activity and thus their
TABLE I. Cohorts’ characteristics
Patients (n526) Controls (n522) P
Age 36.16 1.4 33.56 1.7 0.23
Sex (F/M) 21/5 16/6 0.518
Disease duration (months) 21.76 6.1 – –
EDSS score (median, range) 1.5, 0–3.0 – –
Mean 9-HPT (Right) 17.86 0.4 15.86 0.4 0.002
Mean 9-HPT (Left) 19.36 0.7 17.16 0.4 0.01
Mean T25-FW 5.86 0.3 5.36 0.1 0.09
No. correct responses PASAT 3s 43.16 1.9 49.16 2.3 0.05
No. correct responses PASAT 2s 33.86 2.1 40.76 2.4 0.04
No. Gd1 MRI scans 14/26 – –
T2 hyperintense lesion volume (mm3) 2863.66 531.1 – –
8Chi-square test.
Values are reported as mean6 SE, unless indicated otherwise. The 9-HPT and T25-FW are expressed as the mean of two trials. Signifi-
cance is tested using two-tailed unpaired t test, unless stated otherwise. Abbreviations: EDSS5Expanded Disability Status Scale; Gd1
MRI scans5 scan with at least one gadolinium-enhancing lesion; 9-HPT5 9-hole peg test; PASAT5 Paced Auditory Serial Addition
Test; SE5 standard error; T25-FW5 timed 25-foot walk.
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absence in the context of the natural history of the disease
can reflect the dynamics associated with blood brain bar-
rier alteration and repair [Tomassini and Palace, 2009].
While on IFN beta treatment, patients with Gd-activity
at session 1 showed a reduction in MRI disease activity.
Evidence suggests that this reduction, observed after about
12 weeks of treatment, can already reflect the anti-
inflammatory effect of IFN beta [De Stefano et al., 2012;
Pozzilli et al., 1996], thus offering a model to study the
effect of rapid-onset modulation of inflammation on brain
plasticity.
The Effect of the Motor Task and Training on
Brain Functional Responses at Session 1
The motor task used for motor training consisted of the
repetition of visually cued, directionally specific, simple
thumb movements. As expected, this training led to
changes in functional responses of a wide set of regions
involved in visuomotor integration and motor execution
both in patients and in controls [Morgen et al., 2004].
Training-dependent reductions in brain activity were
also different between groups and more pronounced in
the patients in secondary visual areas (V2 and V4) and in
cortical cerebellar regions connected to the primary and
premotor cortices [O’Reilly et al., 2010]. This cluster of
regions is involved in higher visuomotor control.
V2 and V4 are part of the ventral visual pathway that
allows recognition of an object’s characteristics for appro-
priate selection of motor plans [Fogassi et al., 2001; Schu-
botz and von Cramon, 2003]. V2 is involved in the storage
of memory for object recognition and in the conversion of
short-term into longer-term memories of objects [Lopez-
Aranda et al., 2009]. Although both V2 and V4 can be
modulated by attention, V4 shows more pronounced
changes in the spatial profile of its receptive fields with
attention [Moran and Desimone, 1985] and thus is
involved in encoding of stimulus salience. It is tuned for
recognition of object features of intermediate complexity,
like simple geometric shapes. Our task initially relied on
external cues to drive the pace of thumb movements. As
the participants practised the task, the need for attentional
engagement when performing the visually cued move-
ments will have decreased, while the representation of the
cue pacing the task would have been stored as longer-
term memory of the object and incorporated in the internal
sensorimotor model of the body-environment interactions.
The greater reduction in functional signal in visual regions
TABLE II. Main effect of the thumb flexion task (run 1, session 1) in patients and in controls
Patients (n526) Controls (n522)
MNI Coordinates MNI Coordinates
L PMd 10.5 224 214 66 10.2 258 22 34
R PMd 6.5 58 2 34 5.1 56 4 34
L SMC 10.8 234 214 62 10.3 24 22 54
R SMC 6.5 6 4 54 5.1 6 0 54
L M1 11.0 234 220 52 10.6 234 220 52
R M1 6.5 42 212 52 3.2 42 210 52
L S1 10.8 230 234 48 – – – –
L IPL 11.2 252 232 40 11.3 258 236 24
R IPL 6.7 58 222 40 4.3 64 226 24
L SPL 6.3 236 244 48 5.3 234 248 48
R SPL 5.5 38 244 48 4.9 38 252 48
L V3 6.1 228 292 22 3.02 232 294 210
R V3 5.5 30 288 22 – – – –
L V5 6.8 250 266 22 6.1 250 264 22
R V5 6.0 56 260 22 5.6 52 258 22
L Putamen 7.7 224 24 2 7.14 226 0 2
R Putamen 6.1 24 4 22 5.6 24 4 22
L Pallidum 9.1 222 28 2 7.4 220 24 2
R Pallidum 6.4 22 26 2 5.6 22 26 2
L Thalamus (Premotor) 7.2 210 222 2 7.64 212 220 0
R Thalamus (Prefrontal) 7.0 10 220 0 5.7 10 222 0
R Cerebellum (lobule VI) 7.8 6 262 218 9.97 22 266 226
R Cerebellum (lobule VIIIa) 8.0 16 266 254 6.71 18 264 254
Localization of clusters is in Montreal Neurological Institute (MNI) Standard Brain Space. Z score of the peak voxel is reported for each
cluster showing the main effect of the thumb flexion task in patients and in controls (random effects, Z> 2.3, P< 0.05, corrected). Tha-
lamic and cerebellar regions connected to specific cortical regions are reported in brackets.
Abbreviations: PMd5dorsal premotor cortex; SMC5 supplementary motor cortex; M15primary motor cortex; S15primary somato-
sensory cortex; IPL5 intraparietal lobule; SPL5 superior parietal lobule; V5visual cortex; R5 right; L5 left.
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in the patients could be explained by the greater effort
spent in attending to the task at first exposure, before
training, or, alternatively, by the more pronounced need to
re-build an internal model of body-environment interac-
tions with training on the task.
This functional difference in visual areas can be part of a
long-range modulation of higher motor control areas.
Indeed, among the wide range of cortical connections, the
cerebellum has connections with the visual cortices from
lobules V and VI that represent primary sensorimotor zones
[O’Reilly et al., 2010]. These zones contain overlapping
functional connectivity maps for domain-specific motor,
somatosensory, visual and auditory cortices. The connec-
tions between cerebellar lobule V and VI and the extrastri-
ate visual areas reflect the importance of visual information
in motor control, as the cerebellum is essential to calibrate
the relationship between visual and somatosensory/motor
information. Indeed lobule V and VI are relevant for skill
acquisition [Tomassini et al., 2011] and visuomotor adapta-
tion [Della-Maggiore et al., 2009]. The regions showing
more pronounced reductions in functional responses with
training in the patients were localised in lobule V and VI
bilaterally, suggesting that the need for higher motor con-
trol based on external sensory feedback was greater at first
exposure to the task or decreased more pronouncedly with
practice, as an intrinsic modulation within the cerebellum
set up accurately an acquired pattern of movements, possi-
bly in concert with activation of motor-related cortical
regions [Halsband and Lange, 2006].
The Effect of Pharmacological Modulation of
Inflammation on Brain Plasticity
At session 1, patients showed a training-related reduc-
tion in the functional signal of regions involved in higher
visuomotor control that was more pronounced than the
reduction observed in healthy volunteers. We interpreted
these results as an expression of training-related re-build-
ing of an internal model of the body-environment interac-
tions in the patients that required progressively lower
levels of motor control in order to set up accurately an
acquired pattern of movements. Indeed, this larger
practice-induced signal change in visual areas and in func-
tionally connected regions was reduced in the patients in
session 3 compared with session 2. Specifically, we
observed a reduction in training-related signal changes in
secondary visual areas and in connected posterior parietal
Figure 2.
Training-dependent fMRI signal changes in healthy volunteers and
in MS patients during session 1. Maps of training-related fMRI
signal changes (contrasting run 1 vs. run 2) during session 1 are
reported in healthy volunteers (indicated as controls) and in
patients (Z> 2.3, P< 0.05, cluster corrected). Comparison
between patients and controls showed a higher signal reduction
in the patients in regions corresponding to the secondary visual
areas (V2 and V4) and in the cerebellum (lobule V-VI). Abbrevia-
tions: V5 visual cortex; R5 right hemisphere.
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TABLE III. Training-related functional changes
Training-related signal changes (run 1 vs. run 2) during session 1
Patients (n526) Controls (n522)
MNI Coordinates MNI Coordinates
L FP 4.4 240 42 18 – – – –
R FP 4.0 42 46 18 3.1 36 54 8
L IC 2.9 238 2 4 3.2 238 14 24
R IC 3.9 36 2 4 3.1 32 14 8
L Cingulate 5.8 26 10 34 3.5 22 14 28
R Cingulate 5.2 6 14 34 3.0 8 10 36
L BA 4.7 256 4 18 3.0 254 2 18
R BA 4.0 56 10 26 3.6 52 4 26
L PMd 5.3 226 28 46 4.3 252 2 36
R PMd 3.8 50 22 46 3.7 44 2 46
L IPL 5.6 256 226 34 4.4 258 228 34
R IPL 5.2 60 224 34 4.1 62 222 34
L ITG 4.3 248 262 214 4.2 248 258 28
R ITG 5.6 54 260 214 4.9 56 256 28
L S1 5.2 258 222 36 4.0 244 224 36
R S1 3.8 58 214 36 4.7 54 220 36
L V5 5.5 254 270 4 4.2 248 272 28
R V5 4.9 50 260 4 2.9 54 264 28
L Caudate 2.9 218 16 8 – – – –
R Caudate 4.5 16 14 8 – – – –
L Putamen 4.2 226 22 4 3.0 220 10 0
R Putamen 2.9 30 4 6 2.7 22 14 24
L Pallidum 3.7 216 22 0 2.9 216 6 0
R Pallidum 3.0 20 0 0 2.9 20 4 0
L Thalamus (Prefrontal) 3.8 214 222 12 4.0 212 216 0
R Thalamus (Prefrontal) 4.8 10 214 8 – – – –
L Cerebellum (lobule VI) 5.4 224 256 226 4.5 228 266 224
R Cerebellum (lobule VI) 5.3 26 252 228 4.8 26 252 230
L Cerebellum (crus I) 5.4 232 268 226 3.5 238 252 236
R Cerebellum (crus I) 5.0 26 272 226 3.1 34 256 234
L Cerebellum (lobule VIIIa) 4.4 216 266 250 5.0 228 258 256
Training-related signal changes in sessions 2 and 3 in patients only
Session 2 (n524) Session 3 (n524)
MNI Coordinates MNI Coordinates
L FP 3.1 240 38 22 3.8 242 40 16
R FP 3.2 32 48 24 – – – –
L IC 3.5 232 16 4 4.4 232 16 2
R IC 3.0 32 16 4 3.8 38 4 2
L Cingulate 2.9 26 6 40 4.4 28 16 28
R Cingulate 3.6 4 18 28 4.4 10 10 32
L PMv 3.7 256 2 22 4.5 258 4 24
R PMv – – – – 3.2 60 4 24
L S1 3.6 242 242 50 3.3 240 242 50
R S1 3.7 46 234 52 2.8 38 240 50
L IPL 5.6 258 232 34 5.5 262 228 34
R IPL 4.6 62 228 34 5.0 64 228 36
L V1 3.3 210 280 8 – – – –
R V1 3.6 20 274 8 – – – –
L V2 3.3 26 286 22 – – – –
L V5 3.3 250 266 22 2.9 254 264 22
R V5 3.3 46 264 8 – – – –
R Caudate 3.6 16 14 6 – – – –
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and temporal regions. These regions encompass the ventral
and dorsal streams that provide detailed representation of
the visual world transformed into coordinates for skilled
motor behaviour [Goodale and Milner, 1992]. Interestingly,
between-session changes in training-dependent functional
responses were observed also in the right primary
TABLE III. (continued).
Training-related signal changes (run 1 vs. run 2) during session 1
Patients (n526) Controls (n522)
MNI Coordinates MNI Coordinates
L Putamen – – – – 3.8 222 10 0
R Putamen 3.1 26 4 10 3.5 24 10 0
L Thalamus (prefrontal) 3.9 210 218 6 3.5 28 214 0
R Thalamus (prefrontal) 5.3 16 212 6 4.6 10 216 0
L Cerebellum (lobule VI) 3.5 232 252 234 4.2 230 258 232
R Cerebellum (lobule VI) 3.9 30 252 232 4.0 26 264 232
L Cerebellum (crus I) 4.9 240 252 234 3.8 240 248 234
R Cerebellum (crus I) 3.7 48 254 234 4.0 36 252 236
R Cerebellum (lobule VIIIa) 3.3 16 264 256 4.0 10 264 252
Localization of clusters is in Montreal Neurological Institute (MNI) Standard Brain Space. Z score of the peak voxel is reported for each
cluster showing the effect of thumb flexion training in patients and in controls during session 1 and in patients only during session 2 vs. 3
(random effects, Z> 2.3, P< 0.05, corrected). Thalamic and cerebellar regions connected to specific cortical areas are reported in brackets.
Abbreviations: BA5Broca’s area; FP5 frontal pole; IC5 insular cortex; IPL5 inferior parietal lobule; ITG5 inferior temporal gyrus;
PMd5dorsal premotor cortex; PMv5ventral premotor cortex; M15primary motor cortex; S15primary somatosensory cortex;
V5visual cortex; R5 right; L5 left.
Figure 3.
Training-dependent fMRI signal changes in MS patients during ses-
sion 2 vs. session 3. Maps of training-related fMRI signal changes
(contrasting run 1 vs. run 2) are reported in session 2 (before IFN
beta) vs. session 3 (on IFN beta) in patients with MS (Z> 2.3,
P< 0.05, cluster corrected). Comparing session 2 with session 3,
patients showed a reduction of the training-dependent fMRI signal
changes after 12 weeks of IFN beta treatment in a cluster of
regions encompassing the sensorimotor (M1, S1), temporal (MTG),
visual (V2) and parietal (AIPS, IPL, SPL) cortices. Abbreviations.
AIPS5 anterior intraparietal sulcus; IPL5 inferior parietal lobule;
M15 primary motor cortex; MTG5 middle temporal gyrus; S15
primary somatosensory cortex: SPL5 superior parietal lobule.
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sensorimotor cortices. The involvement of the right sensori-
motor cortices (ipsilateral to the trained hand) has been asso-
ciated with functional reorganisation and recovery in MS
[Tomassini et al., 2012b]. Indeed, an increase in functional
responses of the ipsilateral primary sensorimotor cortices has
been associated with increasing levels of hand disability
(Reddy H et al, Brain 2002), while a reduction in the func-
tional signal of these same regions has been observed with
training-related improvements of hand movements [Tomas-
sini et al., 2012a]. In this study, a reduction in functional
changes between session 2 and 3 in these regions argues in
favour of reduced involvement of the ipsilateral cortex in
training-related changes during pharmacological intervention
and suggests that modulation of inflammation may influence
the brain’s functional connectivity at a systems-level, possibly
restoring patterns of normal activity [Pantano et al., 2002,
2005].
The influence of inflammation and its modulation on
brain plasticity is expected on the basis of experimental
evidence [Di Filippo et al., 2008]. Indeed, inflammatory
molecules can interact with plasticity at a synaptic level
[Di Filippo et al., 2014]. Many immune-signalling mole-
cules are expressed in the healthy brain and regulate syn-
aptic function and plasticity [Pribiag and Stellwagen,
2014]. Also, neurons and glial cells can strictly interact
[Perea et al., 2009]. The interaction between the immune
and the nervous systems in the regulation of synaptic plas-
ticity is needed for the physiologic development of neural
circuitries [Wake et al., 2013] and for the regulation of
plasticity and learning-dependent synapse formation [Par-
khurst et al., 2013]. However, during active neuroinflam-
mation, microglial cells become activated and many
immune molecules are released in higher concentrations
with detrimental effects on the induction of brain plastic-
ity. The brains of patients with MS are characterized by
marked signs of immune cells activation/infiltration [Froh-
man et al. 2006], including activation of microglial cells,
even in normal appearing white matter [van Horssen
et al., 2012]. Thus, it is conceivable that the neuroinflam-
matory environment that characterizes MS may interfere
with the neural circuits that subserve systems-level plastic-
ity. Experimental models of neuroinflammation support
this immune-neural interference and extend the concept of
altered immune-neural interactions to dysfunctional
behaviour. The release of reactive oxygen species and pro-
inflammatory cytokines, along with the infiltration of
immune cells and the activation of astrocytes and micro-
glia, has been associated with abnormalities in synaptic
plasticity [Di Filippo et al., 2014] and this altered synaptic
transmission has been shown to parallel an impaired abil-
ity to encode and retain spatial information [Hauss-Wegr-
zyniak et al., 2002; Kim do et al., 2012; Min et al., 2009],
suggesting that inflammation-related impairment in plas-
ticity can also have behavioural consequences.
Training-dependent changes in functional responses
between session 2 and session 3 paralleling the reduction
in MRI disease activity with IFN beta suggest a drug-
related effect of modulated inflammation on plasticity (Fig.
4). The ROIs that are selected on the basis of a difference
between sessions 2 and 3 are regions involved in motor
training. These regions show little difference between ses-
sions 1 and 2 and a more pronounced difference between
sessions 2 and 3, with IFN beta treatment. Should
between-session changes reflect a session effect, they
would be expected to be more pronounced during the first
phase of the study, between sessions 1 and 2, which was
also shorter than the intervention phase and thus more
prone to repetition effects. Also, values from session 3 in
the patients are similar to those of the controls suggesting
a restoration of function in those regions that could result
from reduction in inflammatory activity.
In this study, healthy volunteers were assessed only
once, at session 1. A longitudinal assessment of functional
changes in healthy controls was not included because the
normal state of the brain did not allow us to explore
changes in functional responses with changes in inflamma-
tion and we did not expect any biologically meaningful
sustained effects of 25 minutes of motor training to carry
over between imaging sessions 6 - 12 weeks apart in the
healthy controls.
Limitations of the Study
We studied only one aspect of systems-level brain plastic-
ity that reflects the adaptation of functional responses with
motor training. However, this type of plasticity is the basis
of a resilient, yet adaptable behaviour and is probed in sys-
tems relevant for visuomotor integration, thus proving
important and informative for rehabilitation [Bastian, 2008].
The time frame studied here is limited. While this
restricts our ability to observe further and wider changes
in training-dependent plasticity with longer-term modula-
tion of inflammation, it allows us to pinpoint the anti-
inflammatory treatment effect without introducing the
confounding factor of irreversible disease-related structural
changes that could affect the fMRI data interpretation.
The absence of an untrained group of patients makes it
difficult to rule out completely the possibility that the dif-
ference between runs in each scanning session could be
due to the passage of time rather than to effect of 25-
minute training. However, considering previous evidence
on the successful induction of changes in functional
responses using a similar adaptation task [Morgen et al.,
2004], we assume that the training accounts for most of
the between-run difference in this study.
The patients included in the study had shown some
clinical or sub-clinical activity that made them eligible to
start a disease modifying treatment, thus making the inclu-
sion of a matched patient group acting as untreated con-
trol unethical. However, the lack of a patient group that
could act as an untreated control makes it difficult to dis-
entangle the treatment from the time effect, i.e., the effect
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of drug from the effect of a spontaneous reduction of
active inflammation on the fMRI signal changes. One
could argue that the observed changes in systems-level
plasticity are not necessarily related in all the patients to
the anti-inflammatory effects of IFN beta, which was used
here to promote a rapid-onset and consistent reduction in
inflammatory activity in the patients [De Stefano et al.,
2012] that paralleled training-related changes in functional
responses. Indeed, a reduction in inflammatory activity
resulting from spontaneous evolution of MS lesions may
have contributed to these functional changes [Tomassini
and Palace, 2009]. However, should these changes have
occurred as a result of natural history, they would still
support our research hypothesis concerning the role of
inflammation in altering plasticity.
The difficulty in interpreting the fMRI changes as being
related to the effects of the drug derives from the potential
session effect, i.e., the passage of time. However, the pres-
ence of 3 time points in the study design allows us to
make predictions of signal changes related to the effects of
drug or sessions. Here, we infer a drug effect on the
assumption that changes associated with session effect on
the functional signal would appear most strongly in the
session 1 to session 2 differences, due to practice effects
Figure 4.
Variation in training-induced fMRI signal changes over time in
functionally defined regions of interest (ROIs). In the patients,
differences across sessions in training-related fMRI signal reduc-
tions (contrasting run 1 vs. run 2, with greater reductions shown
as more positive values) are shown in ROIs derived from the
map of the session 2 vs. session 3 contrast. In the healthy volun-
teers (indicated as controls) training-related signal reductions
are reported for session 1 only. In the patients, the training-
related reduction in functional signal was less in session 3 (on
IFN beta) than in session 2 (before IFN beta) and largely stable
from session 1 to session 2 (before IFN beta), suggesting a drug
effect on brain plasticity. Abbreviations: ROI5 region of interest;
S5 session.
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expected to occur more pronouncedly closer to the first
exposure to the task and reducing with repeated exposure.
We suggest, therefore, that the greater between-run
changes in fMRI activity for session 2 vs. 3 would be
mainly due to the effect of reduced inflammation (Fig. 4).
Under this reasoning, the different length of the two study
phases would help to distinguish between session effect
and the effect of modulated inflammation, i.e., the longer
interval between session 2 and 3 made the functional
changes less prone to session effect and thus more likely
to highlight a drug effect. Therefore, we interpret the
changes seen between sessions 2 and 3 as largely due to
the effect of modulated inflammation, but we cannot com-
pletely exclude the potential influence of a residual session
effect.
A specific interaction between drug-induced immunomo-
dulation and mechanisms of synaptic plasticity mediated
by local modulation of cytokines and growth factors may
have also contributed further to changes in systems-level
plasticity. Indeed, IFN beta has been shown to restore defi-
cits of synaptic plasticity in MS patients [Mori et al., 2012]
and this effect may be mediated by a modulation of the
inflammatory milieu, with changes in the cytokine network
that interfere with or favour processes of synaptic plasticity
[del Rey et al., 2013; Khairova et al., 2009].
Finally, we cannot exclude that the changes during IFN
beta treatment in brain functional responses could reflect a
direct effect of IFN beta on mechanisms of brain plasticity.
Although IFN beta only partially crosses the blood-brain
barrier, if directly administered on brain slices, it has the
potential to modulate glutamate neurotransmission [Di Fil-
ippo et al., 2016], opening the possibility of a direct modu-
latory effect of the drug on plasticity, which is
independent from its anti-inflammatory action.
CONCLUSION
Our results suggest that MS inflammation alters short-
term plasticity underlying motor training as reflected in
greater practice-related fMRI signal changes in the patients
in the pre-IFN beta phase when compared to healthy vol-
unteers. Reduction of inflammation with IFN beta seems
to restore this plasticity in the patients, at least within the
range of damage and disability studied here, suggesting
that modulation of MS inflammation can enhance
recovery-oriented strategies that rely on this plasticity.
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